BIIB vs GPN · P/E 21, rev $9.89B vs P/E 24, rev $6.29B
Biogen Inc (BIIB) versus Global Payments Inc (GPN) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Global Payments Inc (GPN) is a specialty business services company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported GPN revenue for 2026-06-30 was $6.29B. Net income was -$1.79B. GPN currently screens at market cap $18.14B and trailing P/E 24.4.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. GPN currently screens at market cap $18.14B and trailing P/E 24.4.
Not investment advice. Open the BIIB and GPN stock pages for the full models.
Not investment advice.